🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Transcutaneous pO₂ Monitoring in PICU

Recruitingn/aAges 1 Month - 18 YearsAllIstanbul Medeniyet University
NCT07478380 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Arterial blood gas analysis is commonly used in pediatric intensive care units (PICUs) to assess oxygen and carbon dioxide levels in critically ill children. However, arterial blood sampling is invasive, can be painful, and may need to be repeated frequently. Transcutaneous monitoring provides a noninvasive method to continuously measure oxygen (pO₂) and carbon dioxide (pCO₂) levels through the skin, but its accuracy in critically ill pediatric patients requires further evaluation. The purpose of this observational study is to compare transcutaneous pO₂ and pCO₂ measurements with arterial blood gas values in pediatric intensive care unit patients. By analyzing paired measurements obtained simultaneously during routine clinical care, this study aims to evaluate the agreement between transcutaneous and arterial measurements, with a particular focus on whether transcutaneous pO₂ can serve

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Eligibility Criteria Inclusion Criteria: * Age between 1 month and 18 years * Admission to the Pediatric Intensive Care Unit (PICU) * Presence of an arterial catheter allowing arterial blood gas (ABG) sampling * Simultaneous or paired transcutaneous pCO₂ and pO₂ monitoring available * Hemodynamically stable at the time of measurement Exclusion Criteria: * Severe skin disease, burns, or local skin infection at the transcutaneous sensor site * Severe peripheral perfusion impairment (e.g., refractory shock or high-dose vasopressor support) * Congenital or acquired conditions interfering with accurate transcutaneous measurements * Technical failure or inability to obtain reliable transcutaneous readings * Missing or incomplete paired ABG-transcutaneous measurement data
💊

What it tests

  • Not listed
📍

Where

1 site
Göztepe Prof. Dr. Süleyman Yalçın City Hospital
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy